Lee Ainslie Bausch Health Companies Inc. Transaction History

Maverick Capital LTD

$4.82 Billion
Q3 2024

A detailed history of Lee Ainslie (Maverick Capital LTD) transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Maverick Capital LTD holds 271,211 shares of BHC stock, worth $2.22 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

271,211

Previous 230,431 17.7%

Holding current value

$2.22 Million

Previous $1.61 Million 37.61%

% of portfolio

0.05%

Previous 0.03%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$5.22 - $8.26 $212,871 - $336,842	40,780 Added 17.7%	271,211 $2.21 Million
Q2 2024 Aug 14, 2024	BUY	$6.1 - $10.41 $1.41 Million - $2.4 Million	230,431 New	230,431 $1.61 Million
Q3 2023 Nov 14, 2023	BUY	$7.69 - $9.71 $930,205 - $1.17 Million	120,963 New	120,963 $994,000
Q3 2022 Nov 14, 2022	BUY	$4.58 - $9.21 $184,564 - $371,144	40,298 New	40,298 $278,000
Q4 2021 Feb 14, 2022	SELL	$23.0 - $29.01 $1.57 Million - $1.98 Million	-68,292 Reduced 87.42%	9,828 $271,000
Q3 2021 Nov 15, 2021	BUY	$25.04 - $30.06 $1.78 Million - $2.14 Million	71,037 Added 1002.92%	78,120 $2.18 Million
Q2 2021 Aug 16, 2021	SELL	$27.43 - $32.7 $28,033 - $33,419	-1,022 Reduced 12.61%	7,083 $208,000
Q1 2021 May 17, 2021	SELL	$21.37 - $34.38 $53,318 - $85,778	-2,495 Reduced 23.54%	8,105 $257,000
Q4 2020 Feb 16, 2021	SELL	$15.31 - $21.12 $1.83 Million - $2.53 Million	-119,761 Reduced 91.87%	10,600 $220,000
Q3 2020 Nov 16, 2020	SELL	$14.88 - $20.13 $344,561 - $466,130	-23,156 Reduced 15.08%	130,361 $2.03 Million
Q2 2020 Aug 14, 2020	BUY	$13.31 - $20.51 $6,375 - $9,824	479 Added 0.31%	153,517 $2.81 Million
Q1 2020 May 15, 2020	BUY	$12.98 - $30.25 $106,955 - $249,260	8,240 Added 5.69%	153,038 $2.37 Million
Q4 2019 Feb 14, 2020	SELL	$18.89 - $31.89 $1.2 Million - $2.02 Million	-63,316 Reduced 30.42%	144,798 $4.33 Million
Q3 2019 Nov 14, 2019	SELL	$20.88 - $25.66 $1.37 Million - $1.68 Million	-65,576 Reduced 23.96%	208,114 $4.55 Million
Q2 2019 Aug 14, 2019	SELL	$20.52 - $26.45 $1.1 Million - $1.42 Million	-53,820 Reduced 16.43%	273,690 $6.9 Million
Q1 2019 May 15, 2019	BUY	$20.23 - $26.29 $2.24 Million - $2.91 Million	110,560 Added 50.96%	327,510 $8.09 Million
Q4 2018 Feb 14, 2019	SELL	$17.64 - $28.32 $986,428 - $1.58 Million	-55,920 Reduced 20.49%	216,950 $4.01 Million
Q3 2018 Nov 14, 2018	BUY	$20.64 - $25.67 $5.63 Million - $7 Million	272,870 New	272,870 $7.01 Million

Others Institutions Holding BHC

# of Institutions

255

Shares Held

253M

Call Options Held

5.53M

Put Options Held

16.5M

View Full List

About Bausch Health Companies Inc.

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.96B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

More about BHC

Track Lee Ainslie's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.

Account